Clinical Trials Browser

Hyperinsulinism × dapagliflozin × Breast × Clear all

NCT05989347 2025-03-19

Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant with Neoadjuvant Therapy

Phase 1 Recruiting

Breast Neoplasms, Hyperinsulinism